EdgarLookup

PATHWARD FINANCIAL, INC. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that PATHWARD FINANCIAL, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
4.6%
Profit Margin
Net income ÷ revenue
0.5%
Return on Assets
Net income ÷ assets
7.36x
Debt-to-Equity
Total liabilities ÷ equity
+5.3%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $839.89M Nov 25, 2025
FY2025 Sep 30, 2024 $797.41M Nov 25, 2025
FY2024 Sep 30, 2023 $727.68M Aug 29, 2025
FY2023 Sep 30, 2022 $601.13M Nov 21, 2023
FY2022 Sep 30, 2021 $549.90M Nov 22, 2022
FY2021 Sep 30, 2020 $498.83M Nov 23, 2021
FY2020 Sep 30, 2019 $486.75M Nov 30, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $38.80M Nov 25, 2025
FY2025 Jun 30, 2025 $42.15M Nov 25, 2025
FY2025 Mar 31, 2025 $74.96M Nov 25, 2025
FY2025 Dec 31, 2024 $29.97M Nov 25, 2025
FY2025 Sep 30, 2024 $33.53M Nov 25, 2025
FY2025 Jun 30, 2024 $44.87M Nov 25, 2025
FY2025 Mar 31, 2024 $69.92M Nov 25, 2025
FY2025 Dec 31, 2023 $34.90M Nov 25, 2025
FY2025 Sep 30, 2023 $25.28M Nov 25, 2025
FY2025 Jun 30, 2023 $36.08M Nov 25, 2025

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $7.17B Nov 25, 2025
FY2025 Sep 30, 2024 $7.53B Nov 25, 2025
FY2024 Jun 30, 2024 $7.51B Aug 29, 2025
FY2024 Mar 31, 2024 $7.42B Aug 29, 2025
FY2024 Dec 31, 2023 $7.90B Aug 29, 2025
FY2025 Sep 30, 2023 $7.50B Nov 25, 2025
FY2024 Jun 30, 2023 $7.44B Aug 29, 2025
FY2024 Mar 31, 2023 $6.86B Aug 29, 2025
FY2024 Dec 31, 2022 $6.65B Aug 29, 2025
FY2024 Sep 30, 2022 $6.74B Aug 29, 2025

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $6.31B Nov 25, 2025
FY2025 Sep 30, 2024 $6.71B Nov 25, 2025
FY2024 Jun 30, 2024 $6.77B Aug 29, 2025
FY2024 Mar 31, 2024 $6.70B Aug 29, 2025
FY2024 Dec 31, 2023 $7.20B Aug 29, 2025
FY2024 Sep 30, 2023 $6.89B Aug 29, 2025
FY2024 Jun 30, 2023 $6.78B Aug 29, 2025
FY2024 Mar 31, 2023 $6.20B Aug 29, 2025
FY2024 Dec 31, 2022 $6.00B Aug 29, 2025
FY2024 Sep 30, 2022 $6.10B Aug 29, 2025

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $858.05M Nov 25, 2025
FY2025 Sep 30, 2024 $822.47M Nov 25, 2025
FY2024 Jun 30, 2024 $748.40M Aug 29, 2025
FY2024 Mar 31, 2024 $719.50M Aug 29, 2025
FY2024 Dec 31, 2023 $704.76M Aug 29, 2025
FY2024 Sep 30, 2023 $619.35M Aug 29, 2025
FY2024 Jun 30, 2023 $656.70M Aug 29, 2025
FY2024 Mar 31, 2023 $661.16M Aug 29, 2025
FY2024 Dec 31, 2022 $647.36M Aug 29, 2025
FY2024 Sep 30, 2022 $633.24M Aug 29, 2025

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 1 Nov 25, 2025
FY2025 Jun 30, 2025 1 Nov 25, 2025
FY2025 Mar 31, 2025 3 Nov 25, 2025
FY2025 Dec 31, 2024 1 Nov 25, 2025
FY2025 Sep 30, 2024 1 Nov 25, 2025
FY2025 Jun 30, 2024 1 Nov 25, 2025
FY2025 Mar 31, 2024 2 Nov 25, 2025
FY2025 Dec 31, 2023 1 Nov 25, 2025
FY2025 Sep 30, 2023 0 Nov 25, 2025
FY2025 Jun 30, 2023 1 Nov 25, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 1 Nov 25, 2025
FY2025 Jun 30, 2025 1 Nov 25, 2025
FY2025 Mar 31, 2025 3 Nov 25, 2025
FY2025 Dec 31, 2024 1 Nov 25, 2025
FY2025 Sep 30, 2024 1 Nov 25, 2025
FY2025 Jun 30, 2024 1 Nov 25, 2025
FY2025 Mar 31, 2024 2 Nov 25, 2025
FY2025 Dec 31, 2023 1 Nov 25, 2025
FY2025 Sep 30, 2023 0 Nov 25, 2025
FY2025 Jun 30, 2023 1 Nov 25, 2025

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $120.57M Nov 25, 2025
FY2025 Sep 30, 2024 $158.34M Nov 25, 2025
FY2024 Jun 30, 2024 $298.93M Aug 29, 2025
FY2024 Mar 31, 2024 $347.89M Aug 29, 2025
FY2024 Dec 31, 2023 $671.63M Aug 29, 2025
FY2024 Sep 30, 2023 $375.58M Aug 29, 2025
FY2024 Jun 30, 2023 $515.27M Aug 29, 2025
FY2024 Mar 31, 2023 $432.60M Aug 29, 2025
FY2024 Dec 31, 2022 $369.17M Aug 29, 2025
FY2024 Sep 30, 2022 $388.04M Aug 29, 2025

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Sep 30, 2025 $33.46M Nov 25, 2025
FY2025 Sep 30, 2024 $33.35M Nov 25, 2025
FY2024 Jun 30, 2024 $33.33M Aug 29, 2025
FY2024 Mar 31, 2024 $33.37M Aug 29, 2025
FY2024 Dec 31, 2023 $33.61M Aug 29, 2025
FY2024 Sep 30, 2023 $33.87M Aug 29, 2025
FY2024 Jun 30, 2023 $34.18M Aug 29, 2025
FY2024 Mar 31, 2023 $34.54M Aug 29, 2025
FY2024 Dec 31, 2022 $34.98M Aug 29, 2025
FY2024 Sep 30, 2022 $36.03M Aug 29, 2025